Skip to content

Member

Tiemo WÖLKEN

S&D · Germany

Group
S&D
Country
Germany
Roll-call participation
69.2 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
96.7 %ⓘ of 429 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
SPD Sozialdemokratische Partei Deutschlands
In office
Since 16 Jul 2024
Against clear line
10 of 423 votesⓘ
Committees
ENVI, JURI (substitute), SANT
Member id
185619
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

69.2 %

429 of 620 final votes while in office

S&D median: 89.5 % (−20.3 pts)

Chamber median: 90.6 %

With majority line ⓘ

96.7 %

415 of 429 votes where their group had a line

S&D median: 97.1 % (−0.4 pts)

Against clear line ⓘ

2.4 %

10 of 423 votes where their group had a clear line

4 opposite (for ↔ against), 6 abstained against the line

Abstention ⓘ

2.6 %

11 of 429 votes cast

Participation 69.2 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Tiemo WÖLKEN69.2 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 96.7 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Tiemo WÖLKEN96.7 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
29 Apr 2026Discharge 2024: European Public Prosecutor’s Office Discharge decision adopted 454 for, 161 against, 29 abstainedPosition: For Majority line: For
29 Apr 2026Discharge 2024: Agencies Discharge decision adopted 475 for, 107 against, 71 abstainedPosition: For Majority line: For
29 Apr 2026Discharge 2024: Joint Undertakings Discharge decision adopted 525 for, 104 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/008 BE/Liberty - Belgium Passed 586 for, 48 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Genetically modified soybean MON 94637 Objection passed 412 for, 145 against, 11 abstainedPosition: For Majority line: For
29 Apr 2026Situation of fundamental rights in the European Union in 2024 and 2025 Adopted 328 for, 199 against, 98 abstainedPosition: For Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Adopted 387 for, 191 against, 46 abstainedPosition: For Majority line: For
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Adopted 416 for, 190 against, 15 abstainedPosition: For Majority line: For
28 Apr 2026Generalised scheme of tariff preferences Passed 459 for, 127 against, 70 abstainedPosition: For Majority line: For
28 Apr 2026Welfare of dogs and cats and their traceability Passed 558 for, 35 against, 52 abstainedPosition: For Majority line: For
28 Apr 2026Amendments to Biocidal Products Regulation as regards the extension of certain data protection periods Passed 591 for, 54 against, 8 abstainedPosition: For Majority line: For
28 Apr 2026European Globalisation Adjustment Fund: workers affected by imminent job displacement Passed 566 for, 67 against, 26 abstainedPosition: For Majority line: For
28 Apr 2026Interim report on the proposal for the multiannual financial framework for 2028-2034 Interim report adopted 370 for, 201 against, 84 abstainedPosition: For Majority line: For
28 Apr 2026Guidelines for the 2027 budget - Section III Adopted 389 for, 191 against, 75 abstainedPosition: For Majority line: For
28 Apr 2026Amendments to Parliament's Rules of Procedure concerning appointments to Union agencies and bodies (Rule 135) Adopted 657 for, 0 against, 3 abstainedPosition: For Majority line: For
28 Apr 2026Control of the financial activities of the European Investment Bank Group – annual report 2024 Adopted 377 for, 254 against, 31 abstainedPosition: Against Majority line: Against
28 Apr 2026Importance of consent-based rape legislation in the EU Adopted 447 for, 160 against, 43 abstainedPosition: For Majority line: For
28 Apr 2026Protection of the European Union’s financial interests – combating fraud – annual report 2024 Rejected 231 for, 389 against, 33 abstainedPosition: Against Majority line: Against
28 Apr 2026The role of ocean diplomacy for the competitiveness of EU fisheries and aquaculture Adopted 430 for, 107 against, 115 abstainedPosition: For Majority line: For
28 Apr 2026Control, transparency and traceability of performance-based instruments Adopted 527 for, 85 against, 33 abstainedPosition: For Majority line: For
28 Apr 2026Enhancing connectivity, preserving cultural heritage and driving local excellence in European tourism – destination management and regional tourism growth Adopted 439 for, 42 against, 129 abstainedPosition: For Majority line: For
28 Apr 2026Extension of the term of office of the Special Committee on the European Democracy Shield Adopted 422 for, 202 against, 9 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Common system for the return of third-country nationals staying illegally in the Union (Return Regulation) Negotiating mandate approved 389 for, 206 against, 32 abstainedPosition: No vote recorded Majority line: Against
26 Mar 2026Combating corruption Passed 581 for, 21 against, 42 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Failed 228 for, 311 against, 92 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Adjustment of customs duties and opening of tariff quotas for the import of certain goods originating in the United States of America Passed 417 for, 154 against, 71 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Non-application of customs duties on imports of certain goods Passed 437 for, 144 against, 60 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI) Passed 569 for, 45 against, 23 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026United Nations Convention on the International Effects of Judicial Sales of Ships Consent given 605 for, 3 against, 9 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026EU-China Agreement: modification of concessions on all the tariff rate quotas included in the EU Schedule CLXXV Consent given 603 for, 3 against, 33 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026EU-Lebanon Agreement for scientific and technological cooperation setting, participation of Lebanon in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 618 for, 6 against, 5 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/005 AT/KTM - Austria Passed 584 for, 39 against, 13 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/007 BE/Casa - Belgium Passed 575 for, 48 against, 10 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Union framework for the national calculation of life-cycle global warming potential Objection failed 208 for, 414 against, 10 abstainedPosition: No vote recorded Majority line: Against
26 Mar 2026Global Gateway – past impacts and future orientation Adopted 371 for, 146 against, 80 abstainedPosition: No vote recorded Majority line: For
12 Mar 2026Calculation of emission credits for heavy-duty vehicles for the reporting periods of the years 2025 to 2029 Passed 473 for, 81 against, 9 abstainedPosition: For Majority line: For
12 Mar 2026Package travel and linked travel arrangements: make the protection of travellers more effective and simplify and clarify certain aspects Passed 537 for, 2 against, 24 abstainedPosition: For Majority line: For
12 Mar 2026Human trafficking and grave human rights violations linked to the recruitment of non-Russian nationals, in particular from Africa, for Russia’s war of aggression in Ukraine Adopted 479 for, 17 against, 43 abstainedPosition: For Majority line: For
12 Mar 2026The arbitrary detention of President Mohamed Bazoum by the junta in Niger Adopted 524 for, 2 against, 29 abstainedPosition: For Majority line: For
12 Mar 2026Case of Elene Khoshtaria and political prisoners under the Georgian Dream regime Adopted 438 for, 37 against, 81 abstainedPosition: For Majority line: For
12 Mar 2026Activities of the European Ombudsman – annual report 2024 Rejected 233 for, 250 against, 76 abstainedPosition: Against Majority line: Against
11 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Passed 458 for, 103 against, 63 abstainedPosition: For Majority line: For
11 Mar 2026Council of Europe Framework Convention on Artificial Intelligence and Human Rights, Democracy and the Rule of Law Consent given 455 for, 101 against, 74 abstainedPosition: For Majority line: For
11 Mar 2026EU-Ecuador Agreement: cooperation between Europol and the Ecuadorian authorities competent for combating serious crime and terrorism Consent given 586 for, 21 against, 11 abstainedPosition: For Majority line: For
11 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/004 BE/Tupperware – Belgium Passed 562 for, 53 against, 19 abstainedPosition: For Majority line: For
11 Mar 2026Framework Agreement on relations between the European Parliament and the European Commission Adopted 446 for, 100 against, 72 abstainedPosition: For Majority line: For
11 Mar 2026Gender pay and pension gap in the EU: state of play, challenges and the way forward, and developing guidelines for the better evaluation and fairer remuneration of work in female-dominated sectors Adopted 458 for, 72 against, 98 abstainedPosition: For Majority line: For
11 Mar 2026European Semester for economic policy coordination 2026 Adopted 392 for, 219 against, 18 abstainedPosition: For Majority line: For
11 Mar 2026European Semester for economic policy coordination: employment and social priorities for 2026 Adopted 404 for, 208 against, 20 abstainedPosition: For Majority line: For
11 Mar 2026EU enlargement strategy Adopted 385 for, 147 against, 98 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 25 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
René REPASI S&DGermany98 % of 4 172 shared93 %
Gabriele BISCHOFF S&DGermany97 % of 4 319 shared93 %
Tobias CREMER S&DGermany97 % of 4 120 shared93 %
Jens GEIER S&DGermany97 % of 3 908 shared93 %
Katarina BARLEY S&DGermany97 % of 3 157 shared93 %
Vivien COSTANZO S&DGermany97 % of 4 360 shared93 %
Udo BULLMANN S&DGermany97 % of 3 698 shared93 %
Matthias ECKE S&DGermany97 % of 4 089 shared93 %
Birgit SIPPEL S&DGermany97 % of 3 778 shared93 %
Delara BURKHARDT S&DGermany97 % of 3 492 shared93 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Gerben-Jan GERBRANDY RenewNetherlands90 % of 4 388 shared86 %
Raquel GARCÍA HERMIDA-VAN DER WALLE RenewNetherlands89 % of 4 390 shared86 %
Martin HOJSÍK RenewSlovakia89 % of 4 146 shared86 %
Ľudovít ÓDOR RenewSlovakia89 % of 4 126 shared86 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 653 shared86 %
Lucia YAR RenewSlovakia89 % of 4 350 shared86 %
Charles GOERENS RenewLuxembourg89 % of 4 074 shared86 %
Michal WIEZIK RenewSlovakia89 % of 4 083 shared86 %
Jana TOOM RenewEstonia89 % of 3 745 shared86 %
Dainius ŽALIMAS RenewLithuania89 % of 4 091 shared86 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Legal AffairsJURI CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with South AfricaD-ZA DelegationMember19 Sept 2024now
Intergroup on Trade UnionsIG10-24 Intergroup / working groupMember31 Jan 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202419 Jan 2025

Show all 8 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2025 and 2026Shadow rapporteurJURI7 Jul 2026
Replacing S&D shadow rapporteur for the Amending Regulations (EU) 2024/1689 and (EU) 2018/1139 as regards the simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI)Trilogue negotiator6 May 2026
Clean corporate vehiclesRapporteurENVI21 Apr 2026
Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex IShadow rapporteurSANT15 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Opinion rapporteurJURI10 Mar 2026
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024Shadow rapporteurJURI17 Nov 2025
Amending Directives 2000/14/EC, 2011/65/EU, 2013/53/EU, 2014/29/EU, 2014/30/EU, 2014/31/EU, 2014/32/EU, 2014/33/EU, 2014/34/EU, 2014/35/EU, 2014/53/EU, 2014/68/EU and 2014/90/EU of the European Parliament and of the Council as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Amending Regulations (EU) No 765/2008, (EU) 2016/424, (EU) 2016/425, (EU) 2016/426, (EU) 2023/1230, (EU) 2023/1542 and (EU) 2024/1781 as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI23 Jun 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteurSANT21 May 2025

Show all 23 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

26 contributions recorded; 2 on behalf of their group; 35 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026Stop gold-plating, relieve SMEs: Member States must implement EU legislation without adding extra bureaucracy (topical debate) Speech · 1 minRead
8 Jul 2026EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate) Speech · 1 minRead
21 May 2026Need for an adaptation of the EU legal framework on sustainable biofuels (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
20 May 2026Reviewing the ETS system to support European competitiveness (topical debate) Speech · 2 minRead
28 Apr 2026Enforcement of the Digital Markets Act (debate) Speech · 1 minRead
28 Apr 2026Presentation of the Better Regulation and Enforcement Communication (debate) on behalf of S&DSpeech · 1 minRead
8 Oct 2025Europe’s automotive future – reversing the ban on the sale of combustion cars in the EU (topical debate) Speech · 2 minRead

Show all 26 recent contributions

Questions and motions, 20

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
10 Jun 2026Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401Priority written questionwith 37 co-authors13 Aug 2026
19 May 2026Biofuels and e-fuels in road transport E-10-2026-002077Written questionwith 5 co-authors14 Jul 2026
15 Apr 2026Cali fund – follow up from COP16 UN Convention on Biodiversity O-10-2026-000017Oral questionwith 2 co-authorsNot yet answered
23 Mar 2026MOTION FOR A RESOLUTION on the Commission delegated regulation of 3 February 2026 supplementing Regulation (EU) 2024/3012 of the European Parliament and of the Council by establishing the certification methodologies for permanent carbon removals activities B-10-2026-0181Motion for a resolutionwith 2 co-authors—
20 Feb 202612 months extension of the Supplementary Protection Certificate within the proposed European Biotech Act P-10-2026-000725Priority written question13 Apr 2026
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
5 Nov 2025Better regulation P-10-2025-004346Priority written question6 Jan 2026
5 Sept 2025A standardised LEZ sticker for cars E-10-2025-003461Written questionwith 3 co-authors8 Dec 2025

Show all 20 questions and motions

Amendments tabled in committee, 75

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT51
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT85
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT66
15 Jul 2026General budget of the European Union for the financial year 2027 - all sections SANT-AM-789117 SANT18
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5332
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5335
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5324
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5310

Show all 75 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Tiemo WÖLKEN”. Member record. memberId 185619. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/185619?nb=all&page=4&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/185619?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-185619,
  author = {{EU Parl Watch Research}},
  title = {{Tiemo WÖLKEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/185619?nb=all&page=4&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/185619?nb=all&page=4&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 185619. Official source: https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}